About BridgeBio Oncology Therapeutics
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information visit BBOTx.com.
Position Summary
The Finance team is seeking a strategic, detail-oriented, and highly motivated Associate Director of Clinical FP&A to support BBOT’s rapidly growing clinical-stage programs. This role will be a key finance business partner to Clinical Operations, Program Leadership, and R&D teams—providing financial guidance and decision support across multiple high-priority assets. This is a highly visible individual contributor role reporting to the Senior Director, FP&A, with direct exposure to the Development leadership team. The ideal candidate will bring deep experience in clinical-stage FP&A, a strong analytical mindset, and the ability to thrive in a dynamic, fast-paced biotech environment.
Key Responsibilities
Key Responsibilities
· Lead end-to-end clinical FP&A support for BBOT’s clinical-stage phase 1–3 programs, including annual budgeting, quarterly forecasting, and scenario planning
· Develop driver-based study cost estimates during protocol design and study start-up, incorporating enrollment curves, site activation, per-patient costs, and pass-through expenses
· Partner closely with Clinical Operations, Clinical Development, Regulatory, Clinical Pharmacology, and Translational Science to track spending against plan for overall study budgets and provide actionable insights on key cost drivers
· In conjunction with Development Leadership and Sr. Director FP&A, Own the clinical components of the long-range plan (LRP), including forecast models and scenario analyses that inform program prioritization and funding strategy
· Support executive reporting, board materials, and investor relations through development of key clinical related financial key performance indicators (KPIs) and dashboards
· Lead financial reviews with functional leaders to ensure transparency, accountability, and early identification of risks and opportunities
· Serve as the subject-matter expert for clinical finance, driving continuous improvement of planning processes, models, and tools
· Own the monthly clinical accruals process, including coordination with Clinical Operations and Accounting, preparation of accrual support, and audit-ready schedules
· Own clinical vendor (e.g., Contract Research Organizations, labs) financial oversight, including CRO budget and contract review, negotiation support, change-order evaluation, and variance analysis
· Contribute to cross-functional initiatives including strategic planning, program valuation, business development diligence, and clinical milestone tracking
Qualifications
· Bachelor’s degree in finance, accounting, economics, or a related field; MBA or CPA preferred
· 8–12 years of progressive FP&A experience, with at least 5 years specifically supporting clinical-stage biotech or pharma programs; experience at small- to mid-size privately held or public companies preferred
· Deep understanding of clinical trial cost structures, study timelines, and R&D accounting principles
· Demonstrated ownership of the clinical trial and R&D accruals process, including CRO contract and change-order analysis
· Track record of collaboration, stakeholder relationship management, and influencing senior leaders and key decision-makers without formal authority
· Demonstrated ability to operate independently as a senior individual contributor, setting priorities and driving work to completion with minimal oversight
· Well-developed analytical skills that demonstrate the ability to drive from data to analysis to insight
· Proven ability to manage multiple priorities, exercise sound judgment, and solve problems under tight deadlines in a fast-paced, entrepreneurial environment
· Advanced financial modeling and Excel skills; experience with planning tools (e.g., Anaplan, Adaptive Planning), ERP systems (e.g., NetSuite), and BI tools (e.g., Power BI, Tableau) is a plus
· Strong working knowledge of U.S. GAAP, particularly as applied to R&D and clinical trial expenses, and its impact on financial results and forward-looking forecasts
· Experience operating within the control and compliance requirements of a public company, including the Sarbanes-Oxley Act (SOX)
· Process-oriented thinker with experience in process design, implementation, and improvement
· Strong written and oral communication skills allowing for presentation of complex financial concepts in a digestible manner to stakeholders with varying degrees of financial experience
· Demonstrated intellectual curiosity in the life sciences industry
Compensation and Benefits
At BBOT, we strive to provide a market-competitive total rewards package that attracts, retains, and rewards the talent needed to advance our mission. Base pay ranges are set using market data for comparable roles at peer biotechnology companies and are differentiated by geography to reflect local labor markets. Individual base pay within the range is determined by a variety of factors, including experience, skills, education, qualifications, internal equity, and geographic location. Actual compensation will vary, and it is not typical to be hired at or near the top of the range for the role.
The anticipated annual base salary range for this position is $180,000 – $241,000 for candidates based in the San Francisco Bay Area and $153,000 – $205,000 for candidates based elsewhere in the United States (national range). Final compensation offer will depend on the candidates location, experience, and qualifications.
Base compensation is part of a robust total rewards offering at BBOT. Additional total rewards elements include an annual performance bonus, stock-based long-term incentives, medical, dental, and vision benefits, a 401(k) plan with employer matching contribution, company-paid life and disability insurance, a wellness stipend, paid parental leave, flexible time off, and a minimum of 15 paid holidays, including a year-end shutdown.